Clinovo
Sunnyvale, US · Founded 2013 · 1 known investors
Clinovo provides staff augmentation services for pharmaceutical and biotech sponsors, embedding specialized clinical research professionals such as CRAs, data managers, and regulatory specialists directly into sponsor teams on a flexible basis. The company serves clinical trial sponsors seeking to scale internal teams with regulated expertise without permanent hiring overhead.
Founders & leadership
AG
Ale GicqueauinPresident & CEO2009–2014
Investors · 1
Reported raises · per SEC filings
Form D private placements$150K disclosed across 1 round · 2013
▶$150KraisedMar 2014 · 6 investors · Other TechnologyRule 506(c)
▶$150KraisedMar 2014 · 6 investors · Other Technology
Rule 506(c)Officers, directors & promoters on the filing
- Ale GicqueauExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $150K
- Minimum investment
- $10K
- Finders' fees
- $120K
- Placement agents
- I-Banker Securities, Inc.
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Clinovo do?
- Clinovo provides staff augmentation services for pharmaceutical and biotech sponsors, embedding specialized clinical research professionals such as CRAs, data managers, and regulatory specialists directly into sponsor teams on a flexible basis. The company serves clinical trial sponsors seeking to scale internal teams with regulated expertise without permanent hiring overhead.
- Who are Clinovo's investors?
- Clinovo's investors include Keiretsu Forum.
- How much funding has Clinovo raised?
- Clinovo has disclosed $150K raised across 1 round.
- Where is Clinovo headquartered?
- Clinovo is headquartered in Sunnyvale, US.